Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

被引：44

作者：

Roche-Lestienne, C. ^{[1
]}

Marceau, A. ^{[2
]}

Labis, E. ^{[1
]}

Nibourel, O. ^{[2
]}

Coiteux, V. ^{[3
]}

Guilhot, J. ^{[1
]}

Legros, L. ^{[5
]}

Nicolini, F. ^{[6
]}

Rousselot, P. ^{[7
]}

Gardembas, M. ^{[8
]}

Helevaut, N. ^{[2
]}

Frimat, C. ^{[2
]}

Mahon, F-X ^{[9
,10
]}

Guilhot, F. ^{[4
]}

Preudhomme, C. ^{[2
]}

机构：

[1] Hop Jeanne de Flandre, Med Genet Lab, Lille, France

[2] CHU Lille, Ctr Biol Pathol, Hematol Lab, F-59037 Lille, France

[3] CHRU, Hop Huriez, Serv Malad Sang, Lille, France

[4] Ctr Hosp Jean Bernard, CIC Inserm 802, Poitiers, France

[5] Hop Archet, Serv Hematol, Nice, France

[6] Hop Edouard Herriot, Pavillon Dept Hematol E, Lyon, France

[7] Hop Andre Mignot, Serv Hematol & Oncol, Le Chesnay, France

[8] CHU Angers, Serv Malad Sang, Angers, France

[9] Univ Victor Segalen, Serv Malad Sang, Bordeaux, France

[10] Univ Victor Segalen, Hematol Lab, Bordeaux, France

来源：

LEUKEMIA | 2011年 / 25卷 / 10期

关键词：

MYELOPROLIFERATIVE NEOPLASMS; PROGRESSION; JAK2;

D O I：

10.1038/leu.2011.139

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1661 / 1664

页数：5

共 8 条

[1] High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
Boultwood, J.
Perry, J.
Zaman, R.
Fernandez-Santamaria, C.
Littlewood, T.
Kusec, R.
Pellagatti, A.
Wang, L.
Clark, R. E.
Wainscoat, J. S.
[J]. LEUKEMIA, 2010, 24 (06) : 1139 - 1145
[2] Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Chou, Wen-Chien
Huang, Huai-Hsuan
Hou, Hsin-An
Chen, Chien-Yuan
Tang, Jih-Luh
Yao, Ming
Tsay, Woei
Ko, Bor-Sheng
Wu, Shang-Ju
Huang, Shang-Yi
Hsu, Szu-Chun
Chen, Yao-Chang
Huang, Yen-Ning
Chang, Yi-Chang
Lee, Fen-Yu
Liu, Min-Chih
Liu, Chia-Wen
Tseng, Mei-Hsuan
Huang, Chi-Fei
Tien, Hwei-Fang
[J]. BLOOD, 2010, 116 (20) : 4086 - 4094
[3] Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis
Khorashad, J. S.
De Melo, V. A.
Fiegler, H.
Gerrard, G.
Marin, D.
Apperley, J. F.
Goldman, J. M.
Foroni, L.
Reid, A. G.
[J]. LEUKEMIA, 2008, 22 (09) : 1806 - 1807
[4] Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
Kosmider, O.
Gelsi-Boyer, V.
Slama, L.
Dreyfus, F.
Beyne-Rauzy, O.
Quesnel, B.
Hunault-Berger, M.
Slama, B.
Vey, N.
Lacombe, C.
Solary, E.
Birnbaum, D.
Bernard, O. A.
Fontenay, M.
[J]. LEUKEMIA, 2010, 24 (05) : 1094 - 1096
[5] IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms
Pardanani, A.
Lasho, T. L.
Finke, C. M.
Mai, M.
McClure, R. F.
Tefferi, A.
[J]. LEUKEMIA, 2010, 24 (06) : 1146 - 1151
[6] Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
Schaub, Franz X.
Looser, Renate
Li, Sai
Hui Hao-Shen
Lehmann, Thomas
Tichelli, Andre
Skoda, Radek C.
[J]. BLOOD, 2010, 115 (10) : 2003 - 2007
[7] IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis
Soverini, S.
Score, J.
Iacobucci, I.
Poerio, A.
Lonetti, A.
Gnani, A.
Colarossi, S.
Ferrari, A.
Castagnetti, F.
Rosti, G.
Cervantes, F.
Hochhaus, A.
Delledonne, M.
Ferrarini, A.
Sazzini, M.
Luiselli, D.
Baccarani, M.
Cross, N. C. P.
Martinelli, G.
[J]. LEUKEMIA, 2011, 25 (01) : 178 - 181
[8] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
Tefferi, A.
[J]. LEUKEMIA, 2010, 24 (06) : 1128 - 1138

← 1 →